Hepatitis C as the cause of chronic non‐A, non‐B hepatitis: High sensitivity of simultaneous measurement of core and non‐structural antibodies
Authors:
- 1 October 1992
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 7 (5) , 459-462
Abstract
First generation serologic tests (ELISA‐1) for hepatitis C virus infection measure antibodies directed against a short non‐structural segment of the virus (anti‐c100‐3). A major disadvantage of this test is that it lacks sensitivity in the identification of hepatitis C virus among patients at risk of infection. Thus, only 70–90% of chronic non‐A, non‐B cases are ELISA‐1 positive. The present study set out to determine whether antibodies directed against the core region would be a more sensitive indicator of hepatitis C virus infection in patients with chronic non‐A, non‐B hepatitis. Sera were studied from 97 patients with raised serum alanine aminotransferase levels for more than 6 months in whom other causes of abnormal alanine aminotransferase were excluded. Using ELISA‐1, 85 sera (87%) were anti‐c100‐3 positive. Sera were then tested for presence of antibody directed against Po, a core peptide of a Japanese strain of hepatitis C virus, using an ELISA method. Eighty‐eight sera (91%) were anti‐Po positive. Among the 12 anti‐c100‐3 negative patients, six were anti‐Po positive. A second generation ELISA for anti‐HCV (ELISA‐2) incorporates a different antibody to the core region (c22‐3) in addition to an expanded non‐structural region, c200, which consists of c100‐3 plus c33c. With these tests, all sera but one were positive, including 11 of 12 ELISA‐1 negative and eight of nine anti‐Po negative sera. It is concluded that most patients considered to have chronic non‐A, non‐B hepatitis on exclusion and risk factor criteria have one or more markers of hepatitis C virus infection. Individual antibody tests against core or non‐structural regions appear to have similar sensitivities (85–90%), but the results supplement each other. Thus, the sensitivity of a commercially available second generation ELISA test (which combines one core and two non‐structural antibodies) approached 100% in this study and represents a major advance in the diagnosis of hepatitis C.Keywords
This publication has 18 references indexed in Scilit:
- Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?Australian and New Zealand Journal of Medicine, 1991
- The virology of hepatitis CJournal of Gastroenterology and Hepatology, 1991
- Massive Sero–epidemiological Survey of Hepatitis C Virus: Clustering of Carriers on the Southwest Coast of Tsushima, JapanJapanese Journal of Cancer Research, 1991
- Chronic non‐A, non‐B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progressionAustralian and New Zealand Journal of Medicine, 1990
- Detection of hepatitis C viral sequences in non-A, non-B hepatitisThe Lancet, 1990
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDSThe Lancet, 1989
- HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAINThe Lancet, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989